Fred Turner (entrepreneur)

Fred Turner is biotechnology entrepreneur and founder and CEO of Curative, Inc.[1][2][3][4] He was featured in the Science Council list of top 100 practicing scientists in the UK in 2013 and was ranked #1 in the European Union Contest for Young Scientist in 2013.[5][6] Turner was also featured on the 2017 Forbes 30 Under 30 in Science list.[7]

Early life and education

As a 17-year old, Fred won the UK's Young Engineer of the Year Award for building a PCR device intended to find the gene responsible for his brother's red hair.[3] He went to Oxford to study biochemistry but dropped out.[4]

Career

Turner moved from the UK to San Francisco to found TL BioLabs, which made genetic tests for cow herds. TL was backed by the Thiel Foundation.[8] The company pivoted and rebranded to Shield Bio, which had a focus on diagnostic testing for gonorrhea and sepsis.[4] It was backed by 16z and Y-Combinator and the testing was made available to over 10,000 patients in medical centers.[9][10]

Following Shield Bio's closing, Turner founded Curative to focus on improving outcomes for sepsis patients, but the company quickly turned focus to COVID-19 diagnostics in the wake of the COVID-19 pandemic.[11] As of June 2021, his company has conducted over 21 million COVID-19 tests and administered 2 million vaccine doses.[10]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.